Shopping Cart
- Remove All
- Your shopping cart is currently empty
BRD8518, a PCSK9 inhibitor (EC50=0.23 μM), effectively lowers lipid levels by upregulating LDLR expression and enhancing the uptake of LDL. This compound is utilized in cardiovascular disease research.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | BRD8518, a PCSK9 inhibitor (EC50=0.23 μM), effectively lowers lipid levels by upregulating LDLR expression and enhancing the uptake of LDL. This compound is utilized in cardiovascular disease research. |
Molecular Weight | 607.62 |
Formula | C33H32F3N3O5 |
Cas No. | 1565828-01-4 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.